1. Home
  2. ELTX vs ONCY Comparison

ELTX vs ONCY Comparison

Compare ELTX & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • ONCY
  • Stock Information
  • Founded
  • ELTX 2011
  • ONCY 1998
  • Country
  • ELTX United States
  • ONCY Canada
  • Employees
  • ELTX N/A
  • ONCY N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • ELTX Health Care
  • ONCY Health Care
  • Exchange
  • ELTX Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • ELTX 121.7M
  • ONCY 49.1M
  • IPO Year
  • ELTX N/A
  • ONCY 1999
  • Fundamental
  • Price
  • ELTX $7.72
  • ONCY $0.77
  • Analyst Decision
  • ELTX Strong Buy
  • ONCY Strong Buy
  • Analyst Count
  • ELTX 2
  • ONCY 4
  • Target Price
  • ELTX $9.50
  • ONCY $4.33
  • AVG Volume (30 Days)
  • ELTX 57.8K
  • ONCY 1.2M
  • Earning Date
  • ELTX 08-12-2025
  • ONCY 07-31-2025
  • Dividend Yield
  • ELTX N/A
  • ONCY N/A
  • EPS Growth
  • ELTX N/A
  • ONCY N/A
  • EPS
  • ELTX N/A
  • ONCY N/A
  • Revenue
  • ELTX N/A
  • ONCY N/A
  • Revenue This Year
  • ELTX N/A
  • ONCY N/A
  • Revenue Next Year
  • ELTX N/A
  • ONCY N/A
  • P/E Ratio
  • ELTX N/A
  • ONCY N/A
  • Revenue Growth
  • ELTX N/A
  • ONCY N/A
  • 52 Week Low
  • ELTX $3.34
  • ONCY $0.33
  • 52 Week High
  • ELTX $9.99
  • ONCY $1.53
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 55.57
  • ONCY 70.82
  • Support Level
  • ELTX $7.70
  • ONCY $0.56
  • Resistance Level
  • ELTX $8.19
  • ONCY $0.77
  • Average True Range (ATR)
  • ELTX 0.36
  • ONCY 0.09
  • MACD
  • ELTX -0.09
  • ONCY 0.02
  • Stochastic Oscillator
  • ELTX 19.05
  • ONCY 88.51

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: